89bio, Inc (ETNB)
0 followers · Follow
| Sector: | HEALTH CARE |
| Industry: | PHARMACEUTICALS |
| SIC: | PHARMACEUTICAL PREPARATIONS |
| CEO: | Rohan Palekar |
| Employees: | 40 |
| Web site: | 89bio.com |
| 655 MONTGOMERY STREET, SUITE 1500, SAN FRANCISCO, CA, 94111 (415) 432-9270 | |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
89bio, Inc. focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21.
Please log in first to see chart